Similar articles

• Chiroptical properties of fluorescamine condensation compounds with secondary amino acids in situ.

  Toome V, Wegrzynski B, Dell J. Toome V, et al. Biochem Biophys Res Commun. 1976 Jul 26;71(2):598-602. doi: 10.1016/0006-291x(76)90829-9. Biochem Biophys Res Commun. 1976. PMID: 9082 No abstract available.
• Chiroptical properties of fluorescamine condensation compounds with amino acid esters in situ. Pyrrolinone chirality rule.

  Toome V, Wegrzynski B. Toome V, et al. Biochem Biophys Res Commun. 1978 Dec 29;85(4):1496-502. doi: 10.1016/0006-291x(78)91172-5. Biochem Biophys Res Commun. 1978. PMID: 743312 No abstract available.
• Chiroptical properties of fluorescamine condensation compounds with alpha-amino acids in situ.

  Toome V, Wegrzynski B, Reymond G. Toome V, et al. Biochem Biophys Res Commun. 1976 Mar 8;69(1):206-11. doi: 10.1016/s0006-291x(76)80293-8. Biochem Biophys Res Commun. 1976. PMID: 1259758 No abstract available.
• Application of MDPF and fluorescamine XV chiroptical properties of MDPF condensation compounds with dipeptides in situ.

  Toome V, Wegrzynski B. Toome V, et al. Biochem Biophys Res Commun. 1983 Jul 29;114(2):433-9. doi: 10.1016/0006-291x(83)90798-2. Biochem Biophys Res Commun. 1983. PMID: 6882434
• Chiroptical properties of fluorescamine condensation compounds with dipeptides in situ.

  Toome V, Wegrzynski B, Dell J. Toome V, et al. Biochem Biophys Res Commun. 1977 Jan 24;74(2):825-30. doi: 10.1016/0006-291x(77)90377-1. Biochem Biophys Res Commun. 1977. PMID: 836329 No abstract available.